Literature DB >> 12195959

Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties.

Florenz Sasse1, Heinrich Steinmetz, Thomas Schupp, Frank Petersen, Klaus Memmert, Hans Hofmann, Christoph Heusser, Volker Brinkmann, Peter von Matt, Gerhard Höfle, Hans Reichenbach.   

Abstract

A group of cyclic peptides consisting of 8 amino acid residues, named argyrins A to H, were isolated from the culture broth of strains of the myxobacterium Archangium gephyra. Argyrin B was found to be a potent inhibitor of T cell independent antibody formation by murine B cells and strongly inhibited the two way murine mixed lymphocyte reaction. All argyrins had slight antibiotic activity, especially against Pseudomonas sp., and inhibited growth of mammalian cell cultures. The growth inhibition was often incomplete and varied highly with different cell lines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195959     DOI: 10.7164/antibiotics.55.543

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  17 in total

Review 1.  Natural products as probes in pharmaceutical research.

Authors:  Esther K Schmitt; D Hoepfner; P Krastel
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-05       Impact factor: 3.346

2.  Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens.

Authors:  Adriana K Jones; Angela L Woods; Kenneth T Takeoka; Xiaoyu Shen; Jun-Rong Wei; Ruth E Caughlan; Charles R Dean
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  The cyclic octapeptide antibiotic argyrin B inhibits translation by trapping EF-G on the ribosome during translocation.

Authors:  Maximiliane Wieland; Mikael Holm; Emily J Rundlet; Martino Morici; Timm O Koller; Tinashe P Maviza; Domen Pogorevc; Ilya A Osterman; Rolf Müller; Scott C Blanchard; Daniel N Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-02       Impact factor: 12.779

4.  Development of Proteasome Inhibitors as Therapeutic Drugs.

Authors:  Samuel Troy Pellom; Anil Shanker
Journal:  J Clin Cell Immunol       Date:  2012-03-15

5.  Identification of elongation factor G as the conserved cellular target of argyrin B.

Authors:  Beat Nyfeler; Dominic Hoepfner; Deborah Palestrant; Christina A Kirby; Lewis Whitehead; Robert Yu; Gejing Deng; Ruth E Caughlan; Angela L Woods; Adriana K Jones; S Whitney Barnes; John R Walker; Swann Gaulis; Ervan Hauy; Saskia M Brachmann; Philipp Krastel; Christian Studer; Ralph Riedl; David Estoppey; Thomas Aust; N Rao Movva; Zuncai Wang; Michael Salcius; Gregory A Michaud; Gregory McAllister; Leon O Murphy; John A Tallarico; Christopher J Wilson; Charles R Dean
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

6.  Ethyl 2-phenyl-5-trifluoro-methyl-1,3-thia-zole-4-carboxyl-ate.

Authors:  Hai-Zhen Jiang; Wen Wan; Min Shao; Jian Hao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-24

7.  Structure and biosynthesis of sorangipyranone - a new γ-dihydropyrone from the myxobacterial strain MSr12020.

Authors:  Dorothy A Okoth; Joachim J Hug; Attila Mándi; Tibor Kurtán; Ronald Garcia; Rolf Müller
Journal:  J Ind Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.258

8.  High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae.

Authors:  Galina Sergeev; Sambit Roy; Michael Jarek; Viktor Zapolskii; Dieter E Kaufmann; Ranjan K Nandy; Werner Tegge
Journal:  BMC Microbiol       Date:  2014-02-26       Impact factor: 3.605

9.  Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola.

Authors:  Lucky S Mulwa; Rolf Jansen; Dimas F Praditya; Kathrin I Mohr; Joachim Wink; Eike Steinmann; Marc Stadler
Journal:  Molecules       Date:  2018-02-28       Impact factor: 4.411

Review 10.  Diversity of Myxobacteria-We Only See the Tip of the Iceberg.

Authors:  Kathrin I Mohr
Journal:  Microorganisms       Date:  2018-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.